Member Info for HedgeHogarth

Nobody needs me to 'bang on' about the how good an investment opportunity this is. I have said it all before and nothing has changed.

I am expecting an RNS to drop soon with lots of updates due.

Good tuck to all those invested.

Interesting to see so much of last night's activity deleted. (Luckily, not before i took screenshots)

One of our unwelcome manipulative posters (ALderbaron) had the gaul to advise LTHers to sell their shares before the 'pesky traders do'

Let's be clear about a few things:

1) Alderbaron IS a trader or an agent of such. Pesky is far too pleasant a word to describe the traders who have been littering the HEMO forum with their fabrication

2) LTHers are NOT going to sell any shares because of a manipulative trader's post on this forum.

3) LTHers are NOT selling full stop. They are what is 'says on the tin' LTHers.

4) Whilst this forum has be poisoned by the 'hundereds' of messages from Alderbaron and NotPosting - the reality is incredibly bright for Hemogenyx. It is all there to see in the list of RNS

PS - It may come to nothing - but I have been working on a submission to the FCA. I am in no doubt whatsoever that the activity on here by the manipulative is illegal. I have a record of all posts going back to 2021. It's pretty eyeopening when you plot their activity on the same graph as the share price.

Previous attempts to raise this to the FCA have been halfhearted. This time I have the evidence clearly documented and some of the analysis is pretty powerful.

NotPosting - I am afraid you are simple 'out of touch' and showing just how immature and maniupulative you are.

I am a LTHer - i am consistent - I am genuine - I am applying facts

NEVER will you see me claim to know what the share price will be in the short term. I am a Hemo investor and consequently my horizon is in line with standard advice on investing in shares - long term

IF you have been able to predict short term movements in the share price I can only assume you associated with or have links with a broker or have some sort of inside information. If the FCA don't seem to care, then nor will I

I remain focused on the wonderful progress at Hemogenyx and will continue to invest based on my own view of the current and future value of this company.

Right now, for whatever reason, the share price has dipped unexpectedly and represents a great opportunityto invest or top-up

The irony here is that one of the reasons we are suffering the presence of Alderbaron and NotPosting is BECAUSE of...

- The huge potential here and progress already made (they know and hav stated on multiple occasions hwo undervalued ths company is)

- They know that Hemogenyx have a huge following in the UK and over the pond in the US. Vlad and Sir Marc are excellendtly networked and their progress is not going unnoticed

- In the last year or so we have II on board, Proactive on board and a significant new TR1 investor

- Vlad is not just in for the money - this is personal to Vlad. Many, many peers in the industry know this, they know how talented a scientist he is and they know the importance of having Sir Marc involved.

Whilst the presence of Alderbaron and Notposting make me sick to the stomach - the audacity to post hundreds upon hundreds of manipulative posts that potentially undermine the progress / ease of navigating the financial markets. Luckily Hemo have survived what was a tough time for small Biotechs and small companies a like. They have cash in the bank and many routes to additional investment when they need it.

In could be a few days or a few weeks, but these two will either be cheerleading the Hemo faithful or will go very quiet and let the shareprice climb to its true potential.

Mark my words...

#I care what he thinks - beacause he is consistent and genuine

Unlike NOT POSTING and ALDERBARON who are here to be MANIPULATIVE

JHFH - it is not your role responsibility to have to defend HEMO from an invasion these manipulative posters. You have nothing to defend, full stop

Whatever is going on with the shareprice is a short term thing relating to warrants - some choosing to sell, some choosing to hold

NOTHING HAS CHANGED as far a the progress, potential and value of Hemo. It almost touched £100m mCap a few months ago. Compared to its peers, it can easily justofy a value at multiples of todays mCAP.

The smart money will be buying Hemo shares at this price.

The reason we are seeing hundred of posts in the last few weeks is becasue these 'bad actors' want to make money out of buying and selling Hemo shares

They will post whatever they can, whatever they want, as often as they want to suppress the genuine views of LTHers and other knowledgable folk

Its scandalous that the FCA do not clamp down on their behaviours.

Small private investors deserve better. Patients deserve better.

These individuals have no morals - they do not care if their actions have consequences. This is a business trying to save lives of children right now - yet these grown adults are on here 24/7 trying to smear the porspects. Disgusting

Luckily most shareholders see these people coming from a mile away

All this BS talk about discounted placings is scare tactics

Hemo have made tangible progress in the last 12months. They have 3 clinical assets that underpin a much higher value than the current market cap.

Vlad is on record as exploring non dilutive funding solution. If and when this is announced if will blow all these scummy traders away and then some

gla

Feel sorry for anyone selling during this period of manipulation.

Everything I read on here from Notpostinb and alderbaron is complete garbage and scare tactics

HEMO is in great shape - simple as that.

Sadly, what we are witnessing here is criminal behaviour by these individuals. So sad that the FCA are not competant enough to stamp it out.

Clearly I cannot stop the parasitic posters from adding to these thread - (Notposting and Alderbaron to name 2 of them)

I've just woken up to see a 20% drop in the price. I then logged on to see the manipulative, dishonest posters. It is not rocket science to see the connection.

Then I topped up - did not expect to get shares at this price again. Not loads - but found a couple of £k

Empty vessels....

Three well spoken sayings come to mind when thinking about our 2-3 unwanted visitors....

"empty vessels make the most noise"

"a little knowledge is a dangerous thing"

and

we all know the definition of insanity "keep doing the same things and expecting a different outcome"

Agree with Saint - how do you explain the 25 RNS business updates from Hemogenyx in FY25 Hawyain? That's more than Avacta

Hemo addressing a number of TAMs

AML TAM > £5BN

AntiViral - £100BN

Brain Cancer - £10BN

BioDefence - £50bn in USA alone

Good luck Saint - I hope that both companies are very successful for patients and investors alike.

in the mean time - what just happened?

Contrary to what the traders try to say - two LTHers called out another on being too bullish and rampy. Cos that is what we do - we work with the facts, we add logic and we make credible investments decisions on the balance of risk and reward.

I would say right now - less risk with AVACTA given their progress and a decent reward if they progress successfully, more risk with HEMO but a lot more upside in terms of multipls of todays share price

I'm laughing at my desk right now - seeing these traders and manipulative posters get so agitated and desperate.

For those that are no aware - we are aproaching Christmas. Business tends to quieten down at this time of year. So it could suggest things would slow down at Hemo HQ. But let's look at the evidence....

in 2024 - Hemo released 6 RNS updates in Nov/Dec (including 2 between 19th Dec and 31st Dec)

in 2023 - Hemo released 3 RNS updates in Nov/Dec and a big one on in the first week of the new year (8th Jan)

in 2022 - Hemo released 2 RNS updates in Nov/Dec and a big one on in the first week of the new year (4th Jan)

in 2021 - Hemo released 3 RNS updates in Nov/Dec and a two in the first two weeks of the new year (5th and 12th Jan)

The traders are trying to suggest they are delays. There are no delays - Hemo are working as quickly as they can to progress with Phase 1 Trials whilst simultaneously having conversations about the future of the company and funding with big Pharma behind closed doors. This has involved (1) obtaining the necessary approvals, (2) completing the manufacturing transition to accelerate and broaden the trial and (3) commencing patient search / recruitment. We also know that Hemo will be in ongoing talks to expedite the commercialisation of CAR-T in Europe.

A delay is when something unexpected happens: i.e. FDA imposes a clinical hold

There are NO delays - HEMO are getting on with their job

saint - i tend to agree that bline has got a bit excited in his/her post (sorry bline)

1. i beleive hemogenyx is undervalued now - i think £15-£20 is fair value based on its current position and what it has shared with the market. however, i would not want to suggest the share price is about to blast off from a £9 base. my experience tells me that share prices blast off when you least expect it - so i would be mad to try and predict it.

what i would say though is that every day brings us closer to news and with each day those who have taken out a short position will be getting very agitated. i'm optimistic that we will get a few rns updates this year - hopfully one in november. it is a fact that 'closing short positions' usually has a very positive impact on the share price.

2. i would warn against comparing avacta and hemo share prices. share prices are not a good comparator - i would advise you to focus on mcap. avacta is valued at c7x the value of hemogenyx. avacta is further down the road on trials and has already complete far more significant fund raises than hemo.

as a small private investor my preference is to invest in hemogenyx because where it is at in the biotech life cycle. if the science continues to prove as successful as it as to date i am 100% convinced the share price will be at multiples of today's share price in the next 12-18 months.

anyone on here trying to tell us what the share price will be later todat or tomorrow or next week is talking bs. if they could predict share prices they would not be spending their time on this forum - they would be on a bech somewhere with a ****tail in their hand.

good luck all

Well said Moorcloud.

Socialist - I have no idea who you are or where you come from (like 99% of posters on her) but made I congratulate you on a wonderfully crafted post that is 100% ffactual, fair and credible.

Good luck

Any poster with half a brain cell would know when they are flogging a dead horse. What does that say about our unwanted vistors

Now resorting to 'smoke and mirrors' and pretend code words

I think today's desperation has resorted to suggesting a seller is back - connected to warrants.

Almost certainly our unwanted visitors are in some way linked to a Traders who will have dumped shares before as part of their plan to make some money here. Maybe they have a few left to go - but everything (including some logic) suggests their left with peanuts.

I would tend to concur with the author of this thread - it smells of desperation.

It is not rocket science....

These traders understand the very real, very genine and incredibly significant opportunity. Whilst not guaranteed - there is a very real chance that this marvellous company that is currently valued at £50m today could be worth x10 more in the short-medium term. WHat do I mean by short to medium term - in the next 12-18mths. We won't get any notice of when the RNS lands - these sort of commercial conversation happen behind closed doors - both parties will be under NDA. What do we know - Vlad has stated on numerous occasions that Hemogenyx cannot afford Phase 2/3 and that a deal with Big Pharma for the whole company or for to license one of its clincial assets is the end game. We also know the 'going rate' for promising new drugs that treat cancer

Whilst volume has been releatively low over the last few days - any significant volume has been at a price of £9+. Suggest these are buys and may well be by individuals / organisations who are short and have misjudged the mood music on Hemogenyx.

This is not the Hemogenyx of 2020 / 2021 - The increase in the shareprice is not based on hot air anymore.

- Hemogenyx is a respected clinical stage Biotech

- Phase 1 Trials are well underway for their leading clincial candidate HG-CT-1 (CAR-T) - Safety of the 1st dosage has proved 100% safe and no dosage limiting toxicities identified

- The initial results have paved the way for regulatory clearance to proceed with expansion of trial to the pediatric patient received from FDA and IRB

- Worth rememebering where the trial is taking place - none other than the MD Anderson Cancer Center - a leading center for cancer patient care, research, education, and prevention.

- Hemogenyx are chaired by Sir Marc Feldman - a highly respected, pioneer and incredibly well networked.

- Hemogenyx pipeline extends well beyond the current CAR-T candidate......

- CDX (Bispecific antibody) - Hemogenyx devleopmed in collaboration with Eli Lilly. Hemogenyx secured an license deal and therefore have exclusive global rights

- CBR - unique proprietry candidate with Exclusive IP f, proof of concept (“POC”) is achieved for SARS-COV-2 (COVID19). A possibility to develop a treatment to combat multiple viruses that belong to different viral families. The multi-billion market for viral infections and certain types of cancers. It is being expanded into solid tumors and neurodegenerative diseases

- Hemogenyx moved to a new HQ in 2021 - I'll let Vlad explain the significant..... "Having toured every life sciences option in the New York City area, the choice for our lab's continued growth was clear. With several current and future vivarium options, the opportunity to collaborate with nearby Columbia University and City College, the convenient location for our staff, and Janus's commitment to the life sciences industry and our company, the Mink Building represents an unmatched combination of advantages. We will be growing our staff and operations significantly over the next three years, and this lab and building provide us everything we need. Janus also provides us with the critical flexibility we need for our future, by allowing us to grow out of this lab and into its numerous other properties in the District without penalty

What next?

- Hemogenyx are finalising the transition of manufacturing to"Made Scientific". to accelerate trial.

- Next phase of patient recruitment

- Ongoing commercial discussions with Big Pharm (Behind closed doors)

- Exploring opportunity to expedite commercialistion with Europen partner

- No immediate funding needs - Cash in Bank + £1.5m funding pipeline via issues warrants

Exciting - hey - and only valued at £49m right now. Easy to add a nought to that in 1

The two of them (or possibly the same person) are desperate and their engagement on this forum is as pathetic as it is transparent.

Misquoting seems to be their latest game, they are also frequently incosistent with their own post history

Very low volume today again - as it has been since the end of September.

LTHers are going nowwhere